3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing.
3D-printing
Immediate release
Individualized medicine
Levetiracetam
Paediatrics
Pressure-assisted microsyringe (PAM)
Semi solid extrusion
Journal
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
26
05
2020
revised:
17
08
2020
accepted:
21
09
2020
pubmed:
7
10
2020
medline:
3
8
2021
entrez:
6
10
2020
Statut:
ppublish
Résumé
The establishment of 3D-printing as manufacturing process for oral solid dosage forms enables new options for the individualized medicine. The aim of this work was to develop a novel drug-printing model using pressure-assisted microsyringe (PAM) technology, which allows the precise dispensing of drug substances. Printed tablets with different numbers of layers, mimicking different doses for pediatric subgroups, were analyzed regarding mass variation, friability, thickness and disintegration time. Furthermore, the uniformity of dosage units and the dissolution behavior were investigated. Friability was <0.3% in all cases, which demonstrates the ability of PAM printing to manufacture robust solid dosage. Disintegration results showed the dependency of the disintegration on the number of layers and therefore on the compact mass of polymer. However, all tablets disintegrated within 3 min and fulfilled the requirements of immediate release tablets of the USP and orodispersible tablets according to the Ph. Eur. Results of uniformity dosage units confirmed the successful manufacturing of the intended individualized doses. Drug dissolution appeared to be dependent on the number of layers. An increase of layers resulted in a decrease of the drug release rate. Further, the drug release could be correlated to the surface area/volume (SA/V) ratio.
Identifiants
pubmed: 33022389
pii: S0939-6411(20)30289-7
doi: 10.1016/j.ejpb.2020.09.012
pii:
doi:
Substances chimiques
Anticonvulsants
0
Tablets
0
Levetiracetam
44YRR34555
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-65Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.